Patients are stratified by clinicopathological parameters, such as their Gleason score, assessment of tumor extension (category T), the presence of lymphatic dissemination, and the level of serum preoperative prostate-specific antigen (PSA). This evidence concerns the gene KLK3 and neoplasm.